febuxostat (Compound)

Synonyms:Febuxostat, 144060-53-7, Adenuric, Uloric, 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid, Tei 6720, Feburic, Tei-6720, TMX 67, TMX-67, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid, Zurig, C16H16N2O3S, Febuxostat (Uloric), NSC-758874, 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID, CHEMBL1164729, DTXSID8048650, 101V0R1N2E, 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-, Febuxostat [USAN], NCGC00182059-02, DTXCID1028576, 5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-, SMR002529566, Uloric (TN), CAS-144060-53-7, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid, 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, Donifoxate, Febuxostatum, Febuday, Goturic, Febric, Goutex, Febuxostat (JAN/USAN/INN), Febuxostat [USAN:INN:BAN], UNII-101V0R1N2E, Febuxostat- Bio-X, Feburic (TN), SPIRAMYCINADIPATE, 111GE013, FEBUXOSTAT [MI], FEBUXOSTAT [INN], FEBUXOSTAT [JAN], S1547, FEBUXOSTAT [VANDF], 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid, FEBUXOSTAT [MART.], FEBUXOSTAT [WHO-DD], Febuxostat,Uloric, TMX-67, MLS004774136, MLS006011568, FEBUXOSTAT [EMA EPAR], SCHEMBL249339, GTPL6817, thyl-thiazole-5-carboxylic acid, FEBUXOSTAT [ORANGE BOOK], Febuxostat, >=98% (HPLC), CHEBI:31596, BCPP000233, HMS3264C20, HMS3655C03, HMS3673M21, HMS3743I09, HMS3868J03, MX-67, Pharmakon1600-01504286, ACT06289, BCP02342, WZB81950, Tox21_113004, AC-425, BBL036503, BDBM50320491, FD7322, MFCD00871598, NSC758874, STL559020, AKOS015841695, Tox21_113004_1, BCP9000679, BS-1018, CCG-213303, CS-0403, DB04854, NSC 758874, PB33929, 2-(3-Cyano-4-isobutoxy-phenyl)-4-me, NCGC00182059-03, BC164443, HY-14268, AM20090760, F0847, FT-0601639, SW219283-1, D01206, EN300-122360, AB01274796-01, AB01274796_02, AB01274796_03, Q417296, SR-01000940023, Q-100164, SR-01000940023-2, BRD-K48367671-001-01-8, Z1541759499, 2-(3-cyano-4-isobutyloxy)-phenyl-4-methyl-5-thiazolecarboxylic acid, 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid, 2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID

Pubchem:PUBCHEM:134018

Id:4c922c19-7747-5bcb-83e4-837545139385

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View febuxostat's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for febuxostat.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with febuxostat.

Results found

Linked to

	Label	Description
	BRD-K48367671-001-01-8 Substance (Entity type)	A Substance
	febuxostat (f3eb6f6e-b849-448b-901d-32398d04c2d0) Collection (Entity type)	Metadatata for febuxostat
	DCSTRUCT ID 01137 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01137; PubChem_CID:134018, FILE=drugcentral_drug_01137.json)
	febuxostat negatively regulates NVL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat positively regulates ANPEP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat positively regulates HSPA8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat negatively regulates APBB2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat in similarity relationship with Capecitabine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat negatively regulates ADARB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	febuxostat positively regulates RARRES1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS